We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.32B
1-Year Est. Return 28.11%
This Fund
S&P 500
This Quarter Est. Return
-0.71%
1 Year Est. Return
+28.11%
3 Year Est. Return
+79.27%
5 Year Est. Return
+107.45%
10 Year Est. Return
+287.53%
AUM
$1.32B
AUM Growth
+$160M
Cap. Flow
+$215M
Cap. Flow %
16.31%
Top 10 Hldgs %
32.17%
Holding
279
New
64
Increased
51
Reduced
71
Closed
47

Top Buys

Rank Stock Value
1
KMB icon
Kimberly-Clark
KMB
+$29.4M
2
CSCO icon
Cisco
CSCO
+$15.5M
3
BAC icon
Bank of America
BAC
+$15.4M
4
RRX icon
Regal Rexnord
RRX
+$15.2M
5
VTRS icon
Viatris
VTRS
+$14.5M

Top Sells

Rank Stock Value
1
GLNG icon
Golar LNG
GLNG
+$14M
2
PPLI
People Inc
PPLI
+$14M
3
OI icon
O-I Glass
OI
+$9.23M
4
AXS icon
AXIS Capital
AXS
+$7.79M
5
CAT icon
Caterpillar
CAT
+$7.51M

Sector Composition

Rank Sector Weight
1 Financials 24.44%
2 Industrials 14.2%
3 Healthcare 11.5%
4 Consumer Discretionary 9.05%
5 Technology 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORLY icon
126
O'Reilly Automotive
ORLY
$72.4B
$803K 0.06%
8,700
GPN icon
127
Global Payments
GPN
$22.1B
$774K 0.06%
11,500
CBRE icon
128
CBRE Group
CBRE
$40.8B
$754K 0.06%
5,563
+800
+17% +$122K
DRTS icon
129
Alpha Tau Medical
DRTS
$1.13B
$752K 0.06%
106,423
-75,808
-42% -$535K
MA icon
130
Mastercard
MA
$477B
$749K 0.06%
1,500
SMMT icon
131
Summit Therapeutics
SMMT
$10.9B
$714K 0.05%
37,676
HNRG icon
132
Hallador Energy
HNRG
$718M
$703K 0.05%
43,208
+900
+2% +$16.8K
FLGT icon
133
Fulgent Genetics
FLGT
$559M
$687K 0.05%
+43,234
New +$938K
RVTY icon
134
Revvity
RVTY
$12.3B
$681K 0.05%
7,772
-428
-5% -$42.4K
PLTR icon
135
PUT
Palantir
PLTR
$295B
$658K 0.05%
4,500
-500
-10% -$76.4K
NWSA icon
136
News Corp Class A
NWSA
$14.5B
$657K 0.05%
26,349
BATRA icon
137
Atlanta Braves Holdings Series A
BATRA
$3.53B
$637K 0.05%
13,500
-9,132
-40% -$417K
MU icon
138
Micron Technology
MU
$1.04T
$635K 0.05%
+1,879
New +$736K
BLDR icon
139
Builders FirstSource
BLDR
$7.84B
$617K 0.05%
7,500
+3,000
+67% +$320K
QXO
140
QXO Inc
QXO
$14.2B
$611K 0.05%
31,450
+15,700
+100% +$359K
PRMB
141
Primo Brands
PRMB
$8.24B
$601K 0.05%
31,893
+15,263
+92% +$295K
FNF icon
142
Fidelity National Financial
FNF
$13.9B
$590K 0.04%
12,715
NYT icon
143
New York Times
NYT
$11.6B
$562K 0.04%
6,718
EWY icon
144
iShares MSCI South Korea ETF
EWY
$21.7B
$559K 0.04%
+4,544
New +$569K
CI icon
145
Cigna
CI
$76.6B
$552K 0.04%
2,070
-1,000
-33% -$277K
COP icon
146
ConocoPhillips
COP
$147B
$528K 0.04%
4,000
MCO icon
147
Moody's
MCO
$81.7B
$524K 0.04%
1,200
MS icon
148
Morgan Stanley
MS
$337B
$519K 0.04%
+3,151
New +$546K
ARMK icon
149
Aramark
ARMK
$15B
$489K 0.04%
12,064
-4,413
-27% -$175K
AB icon
150
AllianceBernstein
AB
$3.47B
$487K 0.04%
+13,000
New +$511K

Similar funds

Levin Capital Strategies's Q1 2026 Portfolio in Review

As of Q1 2026, Levin Capital Strategies held 279 positions worth $1.32B, up 14% from $1.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Levin Capital Strategies deployed $215M of net new capital in Q1 2026, opening 64 new positions and adding to 51 existing holdings. Its largest new stake was Cisco: 198,268 shares worth $15.4M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 29% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Golar LNG, an estimated $14M trimmed.

  • Levin Capital Strategies's largest Q1 2026 buy was Cisco: 198,268 shares worth $15.4M.
  • Levin Capital Strategies added most to Kimberly-Clark in Q1 2026, an estimated $29.4M increase.
  • Levin Capital Strategies's biggest Q1 2026 reduction was Golar LNG, cutting an estimated $14M.
  • Levin Capital Strategies fully exited Select Medical in Q1 2026, selling an estimated $2.41M.
  • Levin Capital Strategies's ten largest holdings make up 32% of its $1.32B portfolio in Q1 2026.
  • Levin Capital Strategies opened 64 new positions and closed 47 in Q1 2026.
  • Levin Capital Strategies's portfolio value rose 14% quarter-over-quarter to $1.32B.

Based on Levin Capital Strategies's 13F filing for Q1 2026, filed 13 May 2026.